1
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
Condition(s):Hepatitis B; InterferonLast Updated:October 14, 2020Completed
Interferons: 3527 Clinical Trials, Page 1 of 353
Hide Studies Not Open or Pending
2
Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation
Condition(s):Interferon-A-2B; Relapse; Prevention; Hematopietic Stem Cell TransplantationLast Updated:September 23, 2020Withdrawn
3
Interferon α for the Therapy of Minimal Residual Disease
Condition(s):LeukemiaLast Updated:June 7, 2018Recruiting
4
Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)
Condition(s):Chronic Hepatitis BLast Updated:May 2, 2012Unknown status
5
Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT
Condition(s):Hematological Neoplasms; RecurrenceLast Updated:April 21, 2020Recruiting
6
Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2A
Condition(s):HealthyLast Updated:October 26, 2010Completed
7
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia
Condition(s):Essential ThrombocytopeniaLast Updated:January 13, 2020Recruiting
8
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
Condition(s):Chronic Hepatitis BLast Updated:July 23, 2019Completed
9
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition(s):HIV InfectionLast Updated:April 23, 2019Completed
10
Interferon-α After DLI for the Prevention of Relapse
Condition(s):LeukemiaLast Updated:September 29, 2016Unknown status